Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human UseLabeling for Products That Contain Acetaminophen
thch Tun mua ti rocy.vn c xp hng 5 5 sao Mnh nhn hng nhanh, tri nghim tt
Quality varies by source, so pair reconstitution discipline with strict supplier verification
| Atributo | Retatrutida | Tirzepatida | Semaglutida | |---|---|---|---| | Receptores | GLP-1 + GIP + GCG | GLP-1 + GIP | GLP-1 | | Vida media estimada | ~6 das | ~5 das | ~7 das | | Va estudiada | Subcutnea semanal | Subcutnea semanal | Subcutnea / oral | | Reduccin ponderal fase 2 | Hasta 24.2% | Hasta 22.5% | Hasta 15-17% | | Componente termognico | S (GCG-R) | No | No | Historia y desarrollo Retatrutida (cdigo LY3437943) fue desarrollada por Eli Lilly and Company como evolucin del programa incretnico que dio origen a dulaglutida (mono-GLP-1) y tirzepatida (dual GLP-1/GIP, comercializada como Zepbound)
Get Results or your Money Back We're so confident in these breakthrough weight loss meds that we guarantee youll lose at least 10% of your body weight - or your money back (see terms)
US$ 29.34
US$ 23.40
US$ 28.94
US$ 25.93
US$ 25.60
